Human Gene MIR548AD (ENST00000584780.1) from GENCODE V44
|
|
Sequence and Links to Tools and Databases
|
|
Primer design for this transcript
|
|
RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
|
|
Microarray Expression Data
|
|
Press "+" in the title bar above to open this section.
| |
|
|
Orthologous Genes in Other Species
|
|
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Mouse | Rat | Zebrafish | D. melanogaster | C. elegans | S. cerevisiae |
No ortholog | No ortholog | No ortholog | No ortholog | No ortholog | No ortholog |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
|
| |
|
|
Descriptions from all associated GenBank mRNAs
|
|
HZ408564 - JP 2015528002-A/1161: CHIRAL CONTROL. LG051898 - KR 1020150036642-A/1164: CHIRAL CONTROL. HZ483224 - JP 2015535430-A/3730: TERMINALLY MODIFIED RNA. HZ483284 - JP 2015535430-A/3790: TERMINALLY MODIFIED RNA. HZ793155 - JP 2016504050-A/4900: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. HZ793215 - JP 2016504050-A/4960: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JC515887 - Sequence 6140 from Patent WO2014113089. JC515947 - Sequence 6200 from Patent WO2014113089. LQ073475 - Sequence 3799 from Patent EP2964234. LQ073535 - Sequence 3859 from Patent EP2964234. MA646976 - JP 2017113010-A/4900: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA647036 - JP 2017113010-A/4960: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA734860 - JP 2017140048-A/3730: TERMINALLY MODIFIED RNA. MA734920 - JP 2017140048-A/3790: TERMINALLY MODIFIED RNA. JD360161 - Sequence 341185 from Patent EP1572962. FW364445 - Oligonucleotides for modulating target RNA activity. HI964946 - Sequence 231 from Patent WO2010139812. HI966071 - Sequence 391 from Patent WO2010139811. HI966937 - Sequence 391 from Patent WO2010139810. HV595347 - JP 2010539959-A/728: Micromirs. HV753793 - JP 2012509675-A/31: COMPOSITIONS AND METHODS FOR DETECTING SMALL RNAS, AND USES THEREOF. HV938922 - JP 2011519579-A/1750: Oligonucleotides Containing Arabinose Modified Nucleotides For Treating Inflammation and Neoplastic Cell Proliferation. HW915107 - JP 2015504655-A/65: METHODS FOR DIAGNOSIS AND THERAPEUTIC FOLLOW-UP OF MUSCULAR DYSTROPHIES. HZ074519 - JP 2013535982-A/610: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ083223 - JP 2015513906-A/580: Stem Cell Microparticles. HZ157904 - JP 2015130862-A/728: Micromirs. HZ186758 - JP 2015146814-A/507: Oligonucleotides for modulating target RNA activity. HZ437004 - JP 2015529450-A/580: Stem Cell Microparticles. HZ482237 - JP 2015535430-A/2743: TERMINALLY MODIFIED RNA. HZ482245 - JP 2015535430-A/2751: TERMINALLY MODIFIED RNA. HZ792168 - JP 2016504050-A/3913: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. HZ792176 - JP 2016504050-A/3921: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA400984 - Sequence 231 from Patent WO2011080318. JA401962 - Sequence 231 from Patent WO2011080315. JA402969 - Sequence 231 from Patent WO2011080316. JA405600 - Sequence 231 from Patent EP2336353. JA427338 - Sequence 671 from Patent WO2011072177. JA429126 - Sequence 231 from Patent WO2011095623. JA791779 - Sequence 181 from Patent WO2012089772. JA821229 - Sequence 1750 from Patent EP2285961. JB022410 - Sequence 252 from Patent WO2013026685. JB023073 - Sequence 327 from Patent WO2013026684. JB620704 - Sequence 684 from Patent WO2013063544. JB751183 - Sequence 65 from Patent WO2013087907. JC172208 - Sequence 580 from Patent WO2013150303. JC506848 - Sequence 216 from Patent EP2733220. JC514900 - Sequence 5153 from Patent WO2014113089. JC514908 - Sequence 5161 from Patent WO2014113089. JC573019 - Sequence 580 from Patent WO2014125276. JC582707 - Sequence 580 from Patent WO2014125277. JC737960 - Sequence 216 from Patent WO2014075939. JE954403 - Sequence 580 from Patent WO2015052526. JE956156 - Sequence 580 from Patent WO2015052527. LF137908 - JP 2016507550-A/580: Method of Producing Microparticles. LF160530 - JP 2016513950-A/596: Oligomers with improved off-target profile. LF160788 - JP 2016513950-A/854: Oligomers with improved off-target profile. LF162873 - JP 2016513095-A/580: Stem Cell Microparticles and miRNA. LF953625 - JP 2016534103-A/580: Stem Cell Microparticles and miRNA. LG005970 - KR 1020150004822-A/580: STEM CELL MICROPARTICLES. LG053666 - KR 1020150059168-A/580: STEM CELL MICROPARTICLES. LG240905 - KR 1020160035087-A/580: STEM CELL MICROPARTICLES AND MIRNA. LP726697 - Sequence 391 from Patent EP2883966. LP818967 - Sequence 391 from Patent EP3296406. LP835252 - Sequence 50 from Patent WO2017108535. LP835253 - Sequence 51 from Patent WO2017108535. LP835254 - Sequence 52 from Patent WO2017108535. LP835255 - Sequence 53 from Patent WO2017108535. LP938909 - Sequence 391 from Patent EP3184651. LP939559 - Sequence 50 from Patent EP3184646. LP939560 - Sequence 51 from Patent EP3184646. LP939561 - Sequence 52 from Patent EP3184646. LP939562 - Sequence 53 from Patent EP3184646. LP951926 - Sequence 432 from Patent WO2017157650. LQ072488 - Sequence 2812 from Patent EP2964234. LQ072496 - Sequence 2820 from Patent EP2964234. LQ278470 - Sequence 9 from Patent WO2016066288. LQ724716 - Sequence 349 from Patent WO2018096084. LV470990 - JP 2016534036-A/580: Stem Cell Microparticles and miRNA. LY405412 - KR 1020160117535-A/717: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LZ234115 - JP 2017184756-A/507: Oligonucleotides for modulating target RNA activity. MA260651 - JP 2017505623-A/717: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA645989 - JP 2017113010-A/3913: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA645997 - JP 2017113010-A/3921: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA733873 - JP 2017140048-A/2743: TERMINALLY MODIFIED RNA. MA733881 - JP 2017140048-A/2751: TERMINALLY MODIFIED RNA. MS673524 - Sequence 327 from Patent EP3135774. MS834085 - Sequence 231 from Patent EP3112479. MS901779 - Sequence 252 from Patent EP3156505. HZ482206 - JP 2015535430-A/2712: TERMINALLY MODIFIED RNA. HZ792137 - JP 2016504050-A/3882: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JC514869 - Sequence 5122 from Patent WO2014113089. LF161061 - JP 2016513950-A/1127: Oligomers with improved off-target profile. LQ072457 - Sequence 2781 from Patent EP2964234. MA645958 - JP 2017113010-A/3882: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA733842 - JP 2017140048-A/2712: TERMINALLY MODIFIED RNA. MA804029 - JP 2018183181-A/4900: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA804089 - JP 2018183181-A/4960: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA803042 - JP 2018183181-A/3913: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA803050 - JP 2018183181-A/3921: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA803011 - JP 2018183181-A/3882: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MP129680 - Sequence 580 from Patent EP3470073. MP162603 - Sequence 580 from Patent WO2019069093.
| |
|
|
Other Names for This Gene
|
|
Alternate Gene Symbols: NR_039629, uc032njn.1 UCSC ID: ENST00000584780.1 RefSeq Accession: NR_039629
| |
|
|
Methods, Credits, and Use Restrictions
|
|
Click here
for details on how this gene model was made and data restrictions if any.
| |
|
|
|